Keyphrases
Multiple Myeloma
100%
Zirconium-89 (89Zr)
100%
Preclinical Development
100%
CD38
100%
Daratumumab
100%
Desferrioxamine
100%
Myeloma Cells
18%
Tumor
12%
Positron Emission Tomography-computed Tomography (PET-CT)
12%
Myeloma
12%
Luciferase
12%
5TGM1
12%
SCell
12%
Cell-based
6%
Immunoreactivity
6%
Mouse Model
6%
Cell Signaling
6%
Monoclonal Antibody
6%
Receptor Density
6%
U.S. Food
6%
High Affinity
6%
Biodistribution
6%
Antibody Targeting
6%
Flow Cytometry
6%
Confocal Microscopy
6%
Standardized Uptake Value
6%
Severe Combined Immunodeficient Mice
6%
Tumor Model
6%
Specific Activity
6%
Electrospray Ionization Mass Spectrometry
6%
Conjugation
6%
Thin Layer Chromatography
6%
Dissociation Constant
6%
Cell Microscopy
6%
Chelator
6%
Membrane Glycoproteins
6%
Background Noise
6%
Hematological Cancer
6%
Relapsed or Refractory multiple Myeloma
6%
Tumor Uptake
6%
Injected Dose
6%
Small Animal Imaging
6%
In Vivo Evaluation
6%
Multiple Myeloma Patients
6%
Bioconjugates
6%
Cellular Studies
6%
Image-guided Delivery
6%
Tissue Biodistribution
6%
Therapeutic Radionuclides
6%
Heterogeneity in Responses
6%
Benzyl Isothiocyanate
6%
Saturation Binding Assays
6%
Bioluminescence Image
6%
Plasma B Cell
6%
Skeletal Morbidity
6%
Survival Heterogeneity
6%
Medicine and Dentistry
Deferoxamine
100%
Multiple Myeloma
100%
Zirconium 89
100%
Daratumumab
100%
Neoplasm
18%
Positron Emission Tomography-Computed Tomography
12%
Luciferase
12%
Biodistribution
12%
Myeloma
12%
Myeloma Cell
12%
Polyethylene Terephthalate
12%
Malignant Neoplasm
6%
In Vitro
6%
B Cell
6%
Receptor
6%
Immunoreactivity
6%
Confocal Microscopy
6%
Signal Transduction
6%
Flow Cytometry
6%
SCID Mouse
6%
Radioactive Tracer
6%
Sensitivity and Specificity
6%
Standardized Uptake Value
6%
Monoclonal Antibody
6%
Tumor Model
6%
Glycoprotein
6%
Binding Assay
6%
Thin-Layer Chromatography
6%
Electrospray Mass Spectrometry
6%
Benzyl Isothiocyanate
6%
Hexachlorophene
6%
Radiopharmaceutical
6%
Bioluminescence
6%
Chelating Agent
6%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Zirconium 89
100%
Deferoxamine
100%
Daratumumab
100%
Polyethylene Terephthalate
25%
Neoplasm
18%
Myeloma
18%
Biodistribution
12%
Luciferase
12%
Receptor
6%
Malignant Neoplasm
6%
Mouse Model
6%
Confocal Microscopy
6%
SCID Mouse
6%
Monoclonal Antibody
6%
Flow Cytometry
6%
Electrospray Ionization
6%
Glycoprotein
6%
Tracer
6%
Chelating Agent
6%
Radioisotope
6%
Tumor Model
6%
Hexachlorophene
6%
Benzyl Isothiocyanate
6%
Immunology and Microbiology
Multiple Myeloma
100%
Preclinical Study
100%
Daratumumab
100%
Cluster of Differentiation
100%
Positron Emission Tomography-Computed Tomography
12%
Myeloma Cell
12%
Isotope Labeling
12%
Wild Type
6%
Mouse Model
6%
Blood Plasma
6%
Monoclonal Antibody
6%
B Cell
6%
Signal Transduction
6%
SCID Mouse
6%
Electrospray Mass Spectrometry
6%
Glycoprotein
6%
Immunoreactivity
6%
Dissociation Constant
6%
Receptor Density
6%
Thin-Layer Chromatography
6%
Bioluminescence
6%
Confocal Microscopy
6%